Dual-modality Imaging Research Articles

High-fidelity imaging of drug-induced acute gastritis by using a fluorescent and photoacoustic dual-modal probe with good stability in stomach acid

In consideration of deep tissue imaging and signal fidelity, fluorescent-photoacoustic (PA) dual-modal probes are much more desirable. However, dual-modal imaging of gastritis using molecular probes remains a challenge due to the harsh gastric acid environment in the stomach. Based on the positive correlation between gastritis and cell viscosity, stomach acid-stable and viscosity-activated probes could potentially diagnose gastritis. As a proof of concept, herein, a fluorescent and photoacoustic dual-modal probe (named WSP-1) is revealed for the imaging of drug-induced acute gastritis in vivo. WSP-1 exhibits viscosity-dependent fluorescence emission and photoacoustic signals. A rotatable C–C single bond is incorporated into the D-π-A structure of WSP-1, which could facilitate the formation of the twisted intramolecular charge transfer (TICT) state in a low-viscosity environment (weak fluorescence/PA signal) and the intramolecular charge transfer (ICT) state in a high-viscosity environment (strong fluorescence/PA signal). WSP-1 has demonstrated the capability to target mitochondria and can be utilized to monitor the viscosity enhancement of cells during inflammation. Most importantly, WSP-1 exhibits good optical and structural stability in gastric acid. By leveraging these desirable features of WSP-1, we have achieved fluorescent and 3D photoacoustic in situ imaging of drug-induced acute gastritis following oral administration of WSP-1.

Cross-Modal Consistency for Single-Modal MR Image Segmentation.

Multi-modal magnetic resonance (MR) image segmentation is an important task in disease diagnosis and treatment, but it is usually difficult to obtain multiple modalities for a single patient in clinical applications. To address these issues, a cross-modal consistency framework is proposed for a single-modal MR image segmentation. To enable single-modal MR image segmentation in the inference stage, a weighted cross-entropy loss and a pixel-level feature consistency loss are proposed to train the target network with the guidance of the teacher network and the auxiliary network. To fuse dual-modal MR images in the training stage, the cross-modal consistency is measured according to Dice similarity entropy loss and Dice similarity contrastive loss, so as to maximize the prediction similarity of the teacher network and the auxiliary network. To reduce the difference in image contrast between different MR images for the same organs, a contrast alignment network is proposed to align input images with different contrasts to reference images with a good contrast. Comprehensive experiments have been performed on a publicly available prostate dataset and an in-house pancreas dataset to verify the effectiveness of the proposed method. Compared to state-of-the-art methods, the proposed method can achieve better segmentation. The proposed image segmentation method can fuse dual-modal MR images in the training stage and only need one-modal MR images in the inference stage. The proposed method can be used in routine clinical occasions when only single-modal MR image with variable contrast is available for a patient.

Dual-mode photoacoustic and ultrasonic quantitative evaluation of cancellous bone

Abstract Bone diseases, especially osteoporosis, is highly prevalent, and the chronic consequences often have debilitating effects on patients. Early diagnosis and intervention are desired, but existing bone assessment methods do not allow for regular screening as required for such early detection. We were inspired to explore the potential of photoacoustic (PA) imaging for bone assessment due to its molecular imaging capabilities and its shared advantages with ultrasonics (US). In this study, an experimental system was constructed for PA/US dual-mode imaging of cancellous bone, and the resulting images were analysed based on a new quantitative framework. The results from the quantitative analysis clearly differentiated cancellous bones with varying apparent densities, demonstrating the potential of such a method for efficient bone assessment.

Construction of CXCR4 Receptor-Targeted CuFeSe2 Nano Theranostic Platform and Its Application in MR/CT Dual Model Imaging and Photothermal Therapy.

Targeting, imaging, and treating tumors represent major clinical challenges. Developing effective theranostic agents to address these issues is an urgent need. We introduce an "all-in-one" tumor-targeted theranostic platform using CuFeSe2-based composite nanoparticles (CuFeSe2@PA) for magnetic resonance (MR) and computed tomography (CT) dual model imaging-guided hyperthermia tumor ablation. Plerixafor (AMD3100) is bonded to the surface of CuFeSe2 as a targeting unit. Due to the robust interaction between AMD3100 and the overexpressed Chemokine CXC type receptor 4 (CXCR4) on the membrane of 4T1 cancer cells, CuFeSe2@PA specifically recognizes 4T1 cancer cells, enriching the tumor region. CuFeSe2@PA serves as a contrast agent for T2-weighted MR imaging (relaxivity value of 1.61 mM-1 s-1) and CT imaging. Moreover, it effectively suppresses tumor growth through photothermal therapy (PTT) owing to its high photothermal conversion capability and stability, with minimized side effects demonstrated both in vitro and in vivo. CuFeSe2@PA nanoparticles show potential as dual-mode imaging contrast agents for MR and CT and provide an effective means of tumor treatment through photothermal therapy. The surface modification with Plerixafor enhances the targeting ability of the nanoparticles, performing more significant efficacy and biocompatibility in the 4T1 cancer cell model. The study demonstrates that CuFeSe2@PA is a promising multifunctional theranostic platform with clinical application potential.

Photoacoustic/ultrasound dual-modality imaging of Sentinel lymph node with carbon nanoparticles

Abstract Sentinel lymph node (SLN) biopsy is a widely used method for identifying axillary lymph node metastasis in breast cancer patients, offering an avoidance of unnecessary axillarydissections and a lower incidence of lymphedema and other complications. However, the nuclide localization has added complexity to the procedure due to its accessibility. Methylene blue and other small molecule dyes have been widely used due to their convenience, but they have been found to have lower specificity and sensitivity. Carbon nanoparticles (CNPs), as a new type of tracer, are safe and show improved specificity. However, the significant optical absorption in human tissues still renders the detection of deep lymph nodes challenging. To overcome these challenges, we developed a high-sensitivity ultrasound probe optimized for photoacoustic imaging. Based on the new probe, we constructed a high-sensitivity photoacoustic/ultrasound dual-modality imaging system. A pilot clinical study has been conducted on two patients, preliminarily verifying the system’s ability to locate SLN when combined with the CNPs.

Dual-Modal Optical Imaging of Tissue Perfusion in Response to Cooling Stimulation Facilitates Early Detection of Pressure Ulcer.

Pressure ulcers present a significant human and economic challenge, lacking a reliable method for early detection. To address this, we developed a system capable of early detection by using cooling stimulation and dynamic data acquisition techniques to monitor blood perfusion and skin temperature. The system consists of laser speckle perfusion imaging and thermal imaging. And we performed simulations to demonstrate that the system is capable of detect tissue damage across multiple layers, from superficial to deep. Testing on a rabbit ear model demonstrated that this approach, which combines dynamic perfusion and temperature parameters, effectively distinguishes early pressure ulcer areas from normal skin with a significant p value of 0.0015. This distinction was more precise compared to methods relying solely on static parameters or one parameter. Our study thereby offers a promising advancement in the proactive management and prevention of pressure ulcers.

Preclinical Evaluation of a PSMA Aptamer-Based Bifunctional PET and Fluorescent Probe.

Prostate cancer is the most prevalent malignant tumor affecting male individuals worldwide. The accurate early detection of prostate cancer is crucial to preventing unnecessary diagnosis and subsequent excessive treatment. Prostate-specific membrane antigen (PSMA) has emerged as a promising biomarker for the diagnosis of prostate cancer. In this study, a dual-modality imaging probe utilizing aptamer technology was developed for positron emission tomography/near-infrared fluorescence (PET/NIRF) imaging, and the specificity and sensitivity of the probe toward PSMA were evaluated both in vitro and in vivo. The probe precursor NOTA-PSMA-Cy5 was synthesized via automated solid-phase oligonucleotide synthesis. Subsequently, the PET/NIRF dual-modality probe [68Ga]Ga-NOTA-PSMA-Cy5 was successfully prepared and exhibited favorable fluorescence properties and stability in vitro. The binding specificity of [68Ga]Ga-NOTA-PSMA-Cy5 to PSMA was assessed through flow cytometry, fluorescence imaging, and cellular uptake experiments in LNCaP cells and PC-3 cells. In vivo PET/NIRF imaging studies demonstrated the sensitive and specific binding of [68Ga]Ga-NOTA-PSMA-Cy5 to PSMA. Overall, the PET/NIRF dual-modality probe [68Ga]Ga-NOTA-PSMA-Cy5 shows promise for the diagnosis of prostate cancer and for the fluorescence-guided identification of PSMA-positive cancer lesions during surgical procedures.

An integrated bipolar electrode with shared cathode for dual-mode detection and imaging of CEA

In this paper, we designed a novel shared cathode bipolar electrode chip based on Ohm 's law and successfully constructed a dual-mode dual-signal biosensor platform (DD-cBPE). The device integrates ELISA, ECL, and ECL imaging to achieve highly sensitive detection and visual imaging of carcinoembryonic antigen (CEA). The unique circuit structure of the device not only realizes the dual signal detection of the target, but also breaks the traditional signal amplification concept. The total resistance of the system is reduced by series-parallel connection of BPE, and the total current in the circuit is increased. In addition, Au@NiCo2O4@MnO2 nanozyme activity probe was introduced into the common cathode to enhance the conductivity of the material. At the same time, due to the excellent peroxidase (POD) activity of NiCo2O4@MnO2, the decomposition of H2O2 was accelerated, so that more electrons flowed to the BPE anode, and finally the dual amplification of the ECL signal was realized. The device affects the current in the circuit by regulating the concentration of the co-reactant TPrA, thereby affecting the resistance of the system. Finally, different luminescent reagents emit light at the same potential and the luminous efficiency is similar. In addition, the chip does not need external resistance regulation, which improves the sensitivity of the immunosensor and meets the needs of timely detection. It provides a new idea for the deviceization of bipolar electrodes and has broad application prospects in biosensors, clinical detection, and environmental monitoring.

SERS surgical navigation with postsurgical immunotherapy of local microtumors and distant metastases for improved anticancer outcomes.

The standard of clinical care of most malignant solid cancers is surgery, followed by postsurgical adjuvant therapy, but microtumor lesions left behind after surgery and invisible distant metastases are the major reasons for treatment failure. Here, we report an integrated strategy combining surface-enhanced Raman spectroscopy (SERS) surgical navigation with postsurgical immunotherapy elicited by near-infrared II photothermal treatment and programmed death-1 antibody. The SERS surgical navigation is principally based on the multifunctional optical probes (namely, MATRA probes) integrating with T1-weighted magnetic resonance (MR) imaging, photothermal effect and Raman spectroscopic detection. We demonstrate in a 4T1 breast tumor mouse model that the pre-surgical MR/SERS dual-modal imaging is capable of providing comprehensive tumor information, and intraoperative SERS detection allows accurately delineating the tumor margins and guiding the surgical resection in real time with the least residual microscopic foci. We verify that the postsurgical immunotherapy effectively eradicates those local microtumor lesions and invisible distant metastases, greatly inhibiting the postsurgical cancer recurrence and distant metastasis.

(Invited) Mie Resonant Silicon Nanospheres for Scattering-Fluorescence Dual-Mode Imaging, Medical Diagnosis and Photothermal Therapy

In recent years, a variety of multimodal and multifunctional nanoparticles have been developed for biomedical applications such as cellular imaging, biomolecule detection, and medical diagnosis and treatment. A common platform of multifunction nanoparticles is metallic ones with localized surface plasmon resonances. A drawback of metallic nanoparticles for biomedical applications is the Ohmic loss that leads to fluorescence quenching of attached molecules and local heating under light irradiation. We have been developing metal-free nanoprobes capable of scattering/fluorescence dual-mode imaging, medical diagnosis and photothermal therapy. The nanoprobes are composed of a silicon nanosphere core having Mie resonances in the visible to near infrared range and a fluorophore-doped silica shell [1, 2]. In this presentation, we first show scattering properties of the Mie resonant Si nanospheres. We then discuss the dark-field scattering and photoluminescence images/spectra of the core-shell nanoparticles and demonstrate that the fluorescence spectra are strongly modified by the Mie modes of a silicon nanosphere core by the Purcell effect. We demonstrate in the in vitro imaging of human cancer cells that the developed core-shell nanoparticles work as scattering/fluorescence dual-mode imaging nanoprobes.We then add the capability of glutathione sensing to the core-shell nanoprobes. It is known that the glutathione level tends to be elevated in some kinds of cancers and thus it can be used as a biomarker. To add the capability of glutathione sensing, we cover the surface of the core-shell nanoprobes with manganese oxide (MnO2). MnO2 quenches the fluorescence of the core-shell nanoparticles, and it is recovered if the MnO2 shell is resolved by the reaction with glutathione. Therefore, we can monitor the glutathione level by the fluorescence intensity. The advantage of the dual-mode imaging is that the glutathione level can be monitored by the fluorescence intensity, while the particle position is always monitored by the scattering image.Finally, we discuss the capability of Si nanospheres for photothermal therapy. We show that Si nanospheres exhibit efficient light absorption at the wavelengths of magnetic type Mie resonances such as magnetic dipole (MD) and magnetic quadrupole (MQ) resonances, and can be heated up very easily by light irradiation. An advantage of Si nanospheres compared to plasmonic nanoparticles as a light absorber for photothermal therapy is the much narrower resonances. Because of the narrow resonance, we can easily switch heating and non-heating modes. This means that if we want to heat up a nanoparticle, we can choose a specific wavelength that corresponds to e.g., the MQ mode, while if we want to excite fluorophores without heating, we can choose off-resonance wavelength for the excitation. Another advantage of Si nanospheres is the capability to monitor the temperature by Raman scattering. We show the relation between the temperature, wavelength and the size of silicon nanospheres and discuss the Mie modes suitable for the photothermal therapy application.

Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging.

Although targeted therapy has revolutionized oncotherapy, engineering a versatile oncotherapy nanoplatform integrating both diagnostics and therapeutics has always been an intractable challenge to overcome the limitations of monotherapy. Herein, a theranostics platform based on DI/MP-MB has successfully realized the fluorescence detection of disease marker miR-21 and the gene/photothermal/chemo triple synergetic cancer therapy, which can trace the tumor through photothermal and fluorescence dual-mode imaging and overcome the limitations of monotherapy to improve the treatment efficiency of tumors. DI/MP-MB was prepared by magnetic mesoporous silicon nanoparticles (M-MSNs) loaded with doxorubicin (Dox) and new indocyanine green (IR820), and subsequently coating polydopamine as a "gatekeeper", followed by the surface adsorbed with molecular beacons capable of targeting miR-21 for responsive imaging. Under the action of enhanced permeability retention and external magnetic field, DI/MP-MB were targeted and selectively accumulated in the tumor. MiR-21 MB hybridized with miR-21 to form a double strand, which led to the desorption of miR-21 MB from the polydopamine surface and the fluorescence recovery to realize gene silencing and fluorescence imaging for tracking the treatment process. Meanwhile, with the response to the near-infrared irradiation and the tumor's microacid environment, the outer layer polydopamine will decompose, releasing Dox and IR820 to realize chemotherapy and photothermal therapy. Finally, the ability of DI/MP-MB to efficiently suppress tumor growth was comprehensively assessed and validated both in vitro and in vivo. Noteworthily, the excellent anticancer efficiency by the synergistic effect of gene/photothermal/chemo triple therapy of DI/MP-MB makes it an ideal nanoplatform for tumor therapy and imaging.

Immobilized Drugs on Dual-Mode Imaging Ag2S/BaSO4/PVA Embolic Microspheres for Precise Localization, Rapid Embolization, and Local Antitumor Therapy.

Transcatheter arterial embolization (TAE) in interventional therapy and tumor embolism therapy plays a significant role. The choice of embolic materials that have good biocompatibility is an essential component of TAE. For this study, we produced a multifunctional PVA embolization material that can simultaneously encapsulate Ag2S quantum dots (Ag2S QDs) and BaSO4 nanoparticles (BaSO4 NPs), exhibiting excellent second near-infrared window (NIR-II) fluorescence imaging and X-ray imaging, breaking through the limitations of traditional embolic microsphere X-ray imaging. To improve the therapeutic effectiveness against tumors, we doped the doxorubicin (DOX) antitumor drug into microspheres and combined it with a clotting peptide (RADA16-I) on the surface of microspheres. Thus, it not only embolizes rapidly during hemostasis but also continues to release and accelerate tumor necrosis. In addition, Ag2S/BaSO4/PVA microspheres (Ag2S/BaSO4/PVA Ms) exhibited good blood compatibility and biocompatibility, and the results of embolization experiments on renal arteries in rabbits revealed good embolic effects and bimodal imaging stability. Therefore, they could serve as a promising medication delivery embolic system and an efficient biomaterial for arterial embolization. Our research work achieves the applicability of NIR-II and X-ray dual-mode images for clinical embolization in biomedical imaging.

Integrated line-field optical coherence tomography and scheimpflug imaging for corneal imaging

Previously we demonstrated a combined scanning-point optical coherence tomography (OCT) and Scheimpflug Imaging (SI) system, to provide cross-section images of the corneal layers and the whole anterior segment of the eye simultaneously. However, to fully realise the benefits of this dual imaging modality concept towards clinical practice, it is required that the OCT part of the system can achieve ultra-high axial resolution (<3 µm in air) and faster imaging speeds, without using prohibitively expensive components. To achieve this, a new imaging device integrating line-field OCT and SI, using a supercontinuum light source, is demonstrated. This line-field configuration enables both OCT and SI B-scan to be captured using the same light illumination in a single shot, which is the most significant improvement over single point scanning. This achieves an OCT axial resolution down to 2.1 µm in air (1.6 µm in corneal tissue) and an imaging speed up to 213 kA-Scans/s. Since the OCT and SI capture the identical corneal position and serve as cross-validation, this technique offers a great method for accurately determining the individual corneal thickness and refractive index, thereby minimizing individual variations, which can help determine the extent of cutting or correction needed in vision correction. Moreover, the precise measurement of corneal thickness provided by this technique allows for a better understanding of the biomechanical properties of the cornea. We demonstrate the efficacy of the proposed system by evaluating porcine and bovine eyes ex-vivo for determining the corneal refractive index and thickness.

Abstract We113: Intravascular Theranostic Photoactivation Guided By OCT-NIRF Dual-Modal Imaging Facilitates Inflammation Resolution of High-Risk Plaque

Introduction and Hypothesis: Photoactivation eliminates inflammatory cells and promotes healing, paving the way for atherosclerosis intervention. We hypothesized that intravascular macrophage-targeted near-infrared fluorescence (NIRF) emitting photoactivation could facilitate inflammation resolution and stabilize the inflamed high-risk plaques. Method and Results: We newly fabricated a Dectin-1-targeted photoactivatable theranostic agent through the chemical conjugation of the NIRF-emitting photosensitizer chlorin e6 (Ce6) and the Dectin-1 ligand laminarin (LAM-Ce6). By intravascular OCT-NIRF structural-molecular imaging at 0- vs 4 weeks, LAM-Ce6 under light irradiation through a customized intravascular fiber effectively attenuated inflammatory NIRF signals, resulting in replacement of fibrotic composition in the targeted plaques (Figure A, P &lt;0.01). Mechanistically, one hour after the light irradiation, autophagy was strongly augmented with the formation of autophagolysosomes (Figure B, P &lt;0.001) and an increase of CD206-positive cells at 7 days. Furthermore, TUNEL/RAM11- and CD206/MerTK-positive cells were prominently increased at 1 day, suggestive of enhanced efferocytosis in the treated plaques (Figure C, the white arrow: macrophage associated apoptotic cells, P &lt;0.05). In line with inflammation resolution, photoactivation enhanced the cholesterol efflux regulatory protein ABCA1 and induced TGF-β in macrophages, which subsequently stimulated smooth muscle cells and produced collagen within the lesions (Figure D). Conclusions: The macrophage Dectin-1 targetable intravascular photoactivation assisted by OCT-NIRF catheter imaging could ultimately transit the plaque phenotype to collagen-rich fibrotic one by autophagy-mediated inflammation resolution with a fibrotic replacement. This novel targeted photoactivation is expected to offer new opportunity for the catheter-based theranostic strategy in patients with macrophage/lipid-rich inflamed coronary plaques.

Dual-Mode Imaging System for Early Detection and Monitoring of Ocular Surface Diseases.

The global prevalence of ocular surface diseases (OSDs), such as dry eyes, conjunctivitis, and subconjunctival hemorrhage (SCH), is steadily increasing due to factors such as aging populations, environmental influences, and lifestyle changes. These diseases affect millions of individuals worldwide, emphasizing the importance of early diagnosis and continuous monitoring for effective treatment. Therefore, we present a deep learning-enhanced imaging system for the automated, objective, and reliable assessment of these three representative OSDs. Our comprehensive pipeline incorporates processing techniques derived from dual-mode infrared (IR) and visible (RGB) images. It employs a multi-stage deep learning model to enable accurate and consistent measurement of OSDs. This proposed method has achieved a 98.7% accuracy with an F1 score of 0.980 in class classification and a 96.2% accuracy with an F1 score of 0.956 in SCH region identification. Furthermore, our system aims to facilitate early diagnosis of meibomian gland dysfunction (MGD), a primary factor causing dry eyes, by quantitatively analyzing the meibomian gland (MG) area ratio and detecting gland morphological irregularities with an accuracy of 88.1% and an F1 score of 0.781. To enhance convenience and timely OSD management, we are integrating a portable IR camera for obtaining meibography during home inspections. Our system demonstrates notable improvements in expanding dual-mode image-based diagnosis for broader applicability, effectively enhancing patient care efficiency. With its automation, accuracy, and compact design, this system is well-suited for early detection and ongoing assessment of OSDs, contributing to improved eye healthcare in an accessible and comprehensible manner.

Dual-mode object detection algorithm based on feature enhancement and feature fusion

Abstract In complex conditions, visible light cannot meet the challenge of high-precision target detection requirements, so we propose a dual-modal target detection algorithm, named Dual-Mode Object Detection Based on Feature Enhancement and Feature Fusion (DEF). The algorithm in this paper is improved based on YOLOv5. First, we build a dual-branch feature extraction network for visible light and infrared images, separately extracting features of the images. Subsequently, the extracted feature maps are input separately into a feature enhancement module, which is constituted by a multi-branch convolutional architecture and the ECA (Efficient Channel Attention) mechanism, to acquire an augmented set of salient features. Finally, a module for feature fusion is devised to merge the modality-specific features that are extracted by the two branches. The integrated feature maps are then sent into the subsequent module to achieve dual-mode image target detection. The effectiveness of the proposed algorithm is confirmed through a series of experiments conducted using the FLIR and LLVIP datasets, showcasing its superior performance in practical applications.

Emulsion-Based Multi-Phase Integrated Microbeads with Inner Multi-Interface Structure Enable Dual-Modal Imaging for Precision Endovascular Embolization.

Microsphere-based embolic agents have gained prominence in transarterial embolization (TAE) treatment, a critical minimally invasive therapy widely applied for a variety of diseases such as hypervascular tumors and acute bleeding. However, the development of microspheres with long-term, real-time, and repeated X-ray imaging as well as ultrasound imaging remains challenging. In this study, emulsion-based dual-modal imaging microbeads with a unique internal multi-interface structure is developed for TAE treatment. The embolic microbeads are fabricated from a solidified oil-in-water (O/W) emulsion composed of crosslinked CaAlg-based aqueous matrix and dispersed radiopaque iodinated oil (IO) droplets through a droplet-based microfluidic fabrication method. The CaAlg-IO microbeads exhibit superior X-ray imaging visibility due to the incorporation of exceptionally high iodine level up to 221 mgImL-1, excellent ultrasound imaging capability attributed to the multi-interface structure of the O/W emulsion, great microcatheter deliverability thanks to their appropriate biomechanical properties and optimal microbead density, and extended drug release behavior owing to the biodegradation nature of the embolics. Such an embolic agent presents a promising emulsion-based platform to utilize multi-phased structures for improving endovascular embolization performance and assessment capabilities.

High-fidelity imaging of fatty liver in vivo with a fluorescent and photoacoustic dual-mode probe by taking advantage of the liver “first pass effect”

Intravenous injection is the most commonly used method for probe delivery in bio-imaging. While, the oral administration method might be more efficient than intravenous injection for fatty liver imaging due to the existence of liver “first pass effect”. However, this fundamental question has not yet been clarified. Meanwhile, in consideration of the deep tissue imaging and signal fidelity, fluorescent-photoacoustic (PA) dual-mode probes are much more desirable. Herein, an orally administrable dual-mode probe WSP-3 is revealed as a tool for imaging of the fatty liver disease and providing an insight into the above scientific question. A D-π-A system is linked with a rotatable CC single bond in WSP-3, which facilitates the formation of a TICT state in low viscosity environments and an ICT state in high viscosity environments. Base on the positive correlation between fatty liver disease and cell viscosity, dual-mode imaging of non-alcoholic fatty liver disease (NAFLD) and drug-induced fatty liver disease (DIFLD) in vivo was accomplished. Moreover, control experiments indicated that the oral administration method demonstrated higher efficiency in fatty liver disease imaging, providing a fundamental reference for further probe-based fatty liver imaging.

Stable, Scalable, and Free-Standing Perovskite Quantum Dots Composite Reinforced by Cellulose Fibers.

Perovskite quantum dots (PQDs) have attracted emerging attention as fluorescent and light-absorbing materials for next-generation optoelectronics due to their outstanding properties and cost-efficiency. However, PQD thin film suffers significant instability due to structure and material failures, which hinders their application in flexible and reliable PQD-based advanced wearable devices. Herein, we use commercial cellulose fiber-based filter paper as a substrate to synthesize PQDs in situ and fabricate PQD-paper free-standing flexible composite film. The abundant hydroxy capping ligands of cellulose fibers and the unique dense network structure of the filter paper can facilitate confined crystallization, forming strong interactions between the PQDs and substrate, the unpackaged PQD composite film showed extraordinary stability (>30 days) in the air with high humidity (90%). Meanwhile, the strong interaction between PQDs and paper enables an ultrasimple drop-cast synthesis process with excellent process tolerance, making it customizable and easy to scale up (10 cm in diameter). Due to the uniformly dispersed PQDs on cellulose fibers of the substrate, the composite demonstrates impressive photo-responsive properties. Photodetector (PD) arrays were designed on free-standing PQD paper and flexible graphitic electrodes, and circuits were fabricated by drawing. The PD arrays can work as optical and electrical dual-mode image sensors with incredible bending robustness, enduring up to 100,000 cycles at 180°.

MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities

MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities